A. Coulomb and A. Baumelou, Situation de l'automédication en France et perspectives d'évolution : marché, comportements, positions des acteurs. Ministère de la santé et de la protection sociale, 2007.

*. 4+-voisin and P. , Les chiffres clé de l'automédication en 2010, IMS Health France. Mars, 2010.

M. Moulin and A. Coquerel, Pharmacologie 2 ème édition, Editions Masson, pp.133-134, 2002.

S. Mikou, A. Buire, and T. Trenque, Autom??dication chez la femme enceinte, Th??rapie, vol.63, issue.6
DOI : 10.2515/therapie/2008064

I. Damase-michel, J. Christaud, A. Berrebi, I. Lacroix, and J. Montastruc, What do pregnant women know about non-steroidal anti-inflammatory drugs?, Pharmacoepidemiology and Drug Safety, vol.65, issue.11
DOI : 10.1002/pds.1817

I. Lacroix, C. Damase-michel, M. Lapeyre-mestre, and J. Montastruc, Prescription of drugs during pregnancy in France, The Lancet, vol.356, issue.9243, pp.1735-1741, 2000.
DOI : 10.1016/S0140-6736(00)03209-8

F. Brion, D. Cabrol, and G. Moriette, Les médicaments en périnatalogie

A. Ronald, A. Black, and D. Hill, Over the counter medications in pregnancy

B. Shmitt, L'automédication chez la femme enceinte, Hôpitaux universitaires de Strasbourg, 2000.

B. Ofori, D. Oraichi, and . Blais, Risk of congenital anomalies in pregnant users of non-steroidal anti-inflammatory drugs: a nested case-control study, Birth Defects Research Part B: Developmental and Reproductive Toxicology, vol.26, issue.4, pp.268-79, 2006.
DOI : 10.1002/bdrb.20085

G. Nielson, H. Sorensen, and H. Larsen, Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control study, BMJ, vol.322, issue.7281, pp.266-70, 2001.
DOI : 10.1136/bmj.322.7281.266

C. V. Towers, Use of over-the-counter medications in pregnancy. Diseases, complication and drug therapy in obstetric, pp.79-97, 2009.

A. Rhim, J. Hardy, K. Haynes, J. Testani, and Y. Yang, Maternal use of proton pump inhibitors during pregnancy is associated with an increased risk for cardiac birth defects. Program and abstracts of Digestive Disease Week, 2010.

O. Diav-citrin, J. Arnon, and S. Shechtman, The safety of proton pump inhibitors in pregnancy: a multicentre prospective controlled study, Alimentary Pharmacology and Therapeutics, vol.105, issue.3, pp.269-275, 2005.
DOI : 10.1159/000064627

S. Gill, O. Brien, L. Einarson, T. Koren, and G. , The Safety of Proton Pump Inhibitors (PPIs) in Pregnancy: A Meta-Analysis, The American Journal of Gastroenterology, vol.105, issue.6, pp.1541-1545, 2009.
DOI : 10.1016/j.bpg.2007.03.003